PHAS stock forecast
Our latest prediction for PhaseBio Pharmaceuticals Inc - PHAS's stock price was made on the Oct. 28, 2022 when the stock price was at 0.11$.
In the short term (2weeks), PHAS's stock price should underperform the market by -0.21%. During that period the price should oscillate between -14.38% and +16.15%.
In the medium term (3months), PHAS's stock price should outperform the market by 41.44%. During that period the price should oscillate between -29.81% and +59.86%.
Get email alertsCreate a solid portfolio with PHAS
About PhaseBio Pharmaceuticals Inc - PHAS
At the moment the company generates 88M USD in revenues.
On its last earning announcement, the company reported a loss of -1.83$ per share.
The book value per share is 1.54$
Three months stock forecastOct. 28, 2022
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88M | 0.92% | -104M | -117.72% | -120M | -1.83 | - | - | 49M | 1.54 | - | - | - |